skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines GanaxoloneQuestion & answer

Ganaxolone · Medicine question

Does liver disease affect treatment?

iatroX medicinesPublished 17 August 2026Reviewed 17 August 2026

The answer

Answer

Severe hepatic impairment markedly increases ganaxolone exposure and requires a modified specialist plan and close clinical review.

Sources for this answer

ZTALMY 50 mg/mL oral suspensionemc · SmPC Current selected SmPC · Version 1

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Ganaxolone

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the Ganaxolone guide

More questions about Ganaxolone

Can ganaxolone be started in an adult?Does ganaxolone replace other anti-seizure treatments?Can ganaxolone be mixed into food or drink?Can ganaxolone be given through a feeding tube?Can ganaxolone be stopped suddenly?Does kidney disease affect treatment?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX